Field Notes: WPP's Stream Tackles Health Issues

Field Notes: WPP's Stream Tackles Health Issues

Stream Health, WPP's "unconference" which took place in Florida earlier this week, provided a diverse and large amount of content in a short amount of time.

Nurses undeterred by internet bans at work: study

Nurses undeterred by internet bans at work: study

Healthcare workers seek out health-related information on their own time, and through internet connections other than ones offered by their employers.

Everyday Health adds payer expert

The media company has added managed-markets expertise to its roster, bringing on the former head of IMS Health's global payer/provider division.

CVS changes name

Parent company CVS Caremark is changing its name to better reflect "its broader health care commitment."

Five things for pharma marketers to know: Wednesday, August 20

Five things for pharma marketers to know: Wednesday, August 20

Novartis explores the virtual care space, a court has dismissed a lawsuit against IPAB, Doctors Without Borders calls the Ebola outbreak "a complete disaster" and Pfizer becomes the first pharma company to pair with the Crohn's and Colitis Foundation of America.

GSK relaunches COPD.com

GSK relaunches COPD.com

The refresh launched soon after the company encouraged investors to take a long view of GSK as the firm posted weak respiratory numbers.

Doctors do not care about your Fitbit

Tech site Venturebeat, citing anonymous sources, says doctors are too overwhelmed and weary to evaluate how many steps you took this weekend.

As Pharma Slowly Opens Up, Patients Are Engaging Themselves

As Pharma Slowly Opens Up, Patients Are Engaging Themselves

Influential patients are reaching critical mass. What can't they do?

Healthy-habit trackers have short-lived appeal

A study indicates consumers stop using them at the six-month mark.

AstraZeneca takes on pediatricians

The American Academy of Pediatricians says an AstraZeneca drug for preemies should be used less often, and the drugmaker is fighting back with an ad campaign that says the new guidelines put too many at risk.

Miss Idaho shows off diabetes pump

NPR reports that the move has made Sierra Sandison a type 1 diabetes hero and that users have given the Facebook photo over 4,000 "likes."

Digital sage Richman returns to healthcare

He started the Dose of Digital blog in 2008, then left healthcare. Now, after more than two years away, Jonathan Richman says he's back in the business.

"Likes" put Zarbee's in FDA crosshairs

"Likes" put Zarbee's in FDA crosshairs

The FDA says the OTC remedy maker's online behavior—including Liking customer Facebook posts—has put the company's drugs in unapproved drug territory.

OPDP slaps Gilead with Untitled Letter

OPDP slaps Gilead with Untitled Letter

The drugmaker received a notice from the advertising watchdog over promotion of hep. B treatment Viread in a sponsored link on Google AdWords.

Key to successful digital outreach: think small

Key to successful digital outreach: think small

Patients want to do more with mobile and see doctors less. Two studies outline the types of digital interventions patients are interested in.

Merck consumer guide gets 21st-century treatment

Merck consumer guide gets 21st-century treatment

The consumer-facing edition of The Merck Manual Go-To Home Guide for Symptoms is being released as a mobile app.

Researchers give FDA social media advice

Researchers give FDA social media advice

Researchers from Boston Children's Hospital, Harvard Medical School and Brigham and Women's Hospital are offering a bit of internet advice for the Food and Drug Administration: do more.

Facebook's clinical trial

The networking site's emotion experiment rankles some in the science and political communities.

Why the US Didn't Do Well at Lions Health

Why the US Didn't Do Well at Lions Health

A US Pharma juror's—and silver Lions Health winner's—opinion on why the Americans didn't fare well in Cannes, and tips for improvement

Omega-3 drugs angle for trig-lowering awareness

Omega-3 drugs angle for trig-lowering awareness

Celebrity endorsement, co-pay cards and online edutainment are some of the ways marketers are dueling for attention in the prescription omega-3 space.

Marketing tone sinks GSK recruiter

GlaxoSmithKline dismissed a marketer over its approach to clinical trial recruiting.

Sifting social media for the "why" behind Rx switching

Sifting social media for the "why" behind Rx switching

Platform lets pharma firms mine big data, and monitor whether millions spent on ad campaigns or medical education are having the desired effect

Clinical researchers dip toe into social media

Clinical researchers dip toe into social media

Researchers are increasingly using social media to recruit patients, albeit oftentimes in an arms-length manner.

FDA Twitter guidance greeted with caution

FDA Twitter guidance greeted with caution

Guidance on promoting products in 140 characters and correcting misinformation serves as a guarded green light, says one observer.

Dr. Oz runs afoul of lawmakers

Lawmakers criticized Columbia University chairman and professor of surgery Dr. Mehmet Oz for calling weight-loss supplements miracles on his TV program, despite lacking scientific proof to support those claims.

FDA releases new draft social media guidance

FDA issued two guidance documents today for industry and its representatives to communicate online about prescription drugs and devices.

CMS site guides patients through insurance coverage

The Centers for Medicare and Medicaid Services launched a new site Monday to help patients understand how to use their health coverage.

HealthKit won't tangle with the FDA

Recent FDA guidelines for health-tracking apps mean Apple's HealthKit, and similar apps, won't have to jump regulatory hurdles before going live.

WebMD seeks to unify health data

WebMD seeks to unify health data

The health and lifestyle resource's latest app seeks to provide context for all that biometric data consumers are storing in wearables, wireless scales and glucometers.

OPDP says phentermine site thin on details

OPDP says phentermine site thin on details

The bad-ad watchdog says the promotional website for the weight-loss medication Suprenza leaves out too much information.

Patients dial up info while waiting for doctor: study

Patients dial up info while waiting for doctor: study

Patients are using their time in the waiting room to better prepare for upcoming discussions with their doctor. That makes it a good time for marketers to offer mobile-friendly info, researchers have found.

Gwee moves to Digitas Health Lifebrands

Gwee moves to Digitas Health Lifebrands

Shwen Gwee, the social media guru, has joined Digitas Health Lifebrands as VP of social strategy.

Sanofi and Lilly to pursue non-Rx Cialis

Sanofi and Lilly to pursue non-Rx Cialis

The two drugmakers inked a deal under which Sanofi holds rights to market the ED pill to consumers without a prescription, if the drug can make the switch.

FDA examines DTC close up

FDA examines DTC close up

The regulator's latest study will use eye-tracking tools.

Texting threatens pagers, work-life balance

Texting HCPs may be speedy, but a study finds some built-in risks.

WebMD: Pollen Vortex is here

The medical website says the country is in for a bad allergy season.

Vieira, Everyday Health team up

Vieira, Everyday Health team up

The two-year collaboration leverages health content from Meredith Vieira's Lives project.

Botox turns 25

The anniversary celebration for the line-smoothing, migraine-relieving medication is expected to last a year.

Ad chides Gilead "greed" over Sovaldi pricing

The AIDS Healthcare Foundation took out an ad in some WSJ editions saying the drug threatens to "break the bank."

Bayer encourages daily calcium with a side of defiance

Its "Beauty is Bone Deep" campaign looks at beauty from the inside.

Wego brings on ex-Sanofi digital lead

Wego Health announced it has added Todd Kolm as SVP, strategy and insights.

Research conflicts not limited to pharma

A piece about obesity and Coca-Cola shows the widespread nature of conflict-of-interest discussions and concerns about the sway that honoraria and other goodies may exert on researchers.

Janssen recruits Debbie Allen for T2 Diabetes

Actress, choreographer and "So You Think You Can Dance" judge Debbie Allen has signed on to participate with the drugmaker's type 2 diabetes awareness and wellness program.

Crowdsourcing patient information

23andMe cofounder Linda Avey is taking crowdsourced patient experiences to the web with a soft July launch of a platform called Curious.

AOL lands J&J marketing vet

AOL lands J&J marketing vet

Praised for helping navigate the shift by advertisers into digital, media vet Kim Kadlec is leaving pharma for a new role at AOL.

Survey shows Pharma digitally failing patients

Survey shows Pharma digitally failing patients

A study by consulting firm Accenture shows that patients not only expect digital outreach, but that their desire to be engaged is consistently being ignored.

Allergan documents eyelash concern

The manufacturer of the so-called "Botox for eyelashes" found the majority of women it surveyed were worried about thinning fringe.

OPDP slams Facebook page

OPDP slams Facebook page

The FDA's bad-ad unit took a drugmaker to task for what it calls a misleading Facebook page. History shows the social media surveillance should take no one by surprise.

Adults increasingly using ADHD medications

Adults increasingly using ADHD medications

Express Scripts notes that these prescriptions may not, in fact, be for ADHD.

Games may not improve memory

The NYT reports that the data on gaming long-term memory is inconclusive.

Nintendo sees future in health

The Mario Bros. company says health and fun are the way of the future.

Takeda admits running bad ads

The company said it used "inappropriate expressions" in promotions of a blood pressure medication.

Remedy debuts long-form sponsored stories

Remedy debuts long-form sponsored stories

The publisher aims to bring patient stories to life through long-form multimedia narratives.

NABP seeks pharmacy oversight

The National Association of Boards of Pharmacy says about 97% of surveyed pharmacy sites fail to comply with laws.

Monitor converts sweat equity to charity

GoQii seeks to convert tracked calories, steps and distance into a philanthropic device.

E-mail increasingly read on mobile devices

Movable Ink reports that 65% of Q4 emails were opened on a tablet or smartphone.

Startup clinical trial app

TapTrak seeks to apply behavioral tracking to clinical trials.

Mobile Marketing Report: The Wellness Game

Mobile Marketing Report: The Wellness Game

Pharma has reduced the burden of disease. It can develop a condition-specific app. But getting people to take their medications as prescribed? That's another matter. Larry Dobrow on why biopharma is backing mobile games for their potential to boost adherence and drive behavior change

IMS researchers urge pharma to get social

IMS researchers urge pharma to get social

The latest IMS report shows that 50% of the top 50 pharma companies are not on social media. Executive Director Murray Aitken tells MM&M it is to pharma's detriment.

Olympics will feature healthcare reform ads

HHS has bought airtime in markets with high numbers of uninsured patients.

Polls highlight chronic disease information needs

Polls highlight chronic disease information needs

Chronic disease patients seek online support and information, and show little love for branded websites.

Genetics and a dig at rivals for the holidays

Spectrum DNA says its genetic services are at the ready, even if 23andMe's are not.

Pfizer is now @Pfizer

The drugmaker now owns the @Pfizer handle in addition to @Pfizer_news

HIV/AIDS site makes healthcare reform personal

HIV/AIDS site makes healthcare reform personal

The Kaiser Family Foundation's just-launched website, funded by Gilead, addresses healthcare reform from a distinct perspective.

Vivus slims down in wake of sluggish sales

Vivus slims down in wake of sluggish sales

The drugmaker says 20 jobs, or 17% of its workforce, will be gone by the end of the year.

Doctors sound off on healthcare reform

They're not hiding their love or disdain for reform, including one who says the law brings bias into the exam room.

HealthTap pursues voice-activated advice

The voice-activated app costs 99 cents.

Health apps come up short in study

Health apps come up short in study

Researchers found that most healthcare apps have limited functionality, don't serve patients with multiple needs, and taper off when support is needed most. No wonder adoption is low.

WebMD is bringing former advertisers back on board

WebMD is bringing former advertisers back on board

The company says it recaptured some former advertisers and that third-quarter traffic is up compared with last year.

Mobile makes users more likely to switch brands: survey

Mobile makes users more likely to switch brands: survey

Smartphone users, while in the exam room, are more apt to be in "switch mentality," a study finds.

FDA exempts most mobile apps from scrutiny

FDA exempts most mobile apps from scrutiny

The agency issued final guidance on mobile apps, saying it will focus only on a subset that present the greatest risk to patients if they don't work correctly.

Patient power taking center stage at event

Patient power taking center stage at event

An upcoming leadership summit is devoted to exploring whether health social media is driving meaningful change, as well as new ways to engage with health activists.

Mylan expands Get Schooled anaphylaxis tool box

Mylan expands Get Schooled anaphylaxis tool box

The EpiPen manufacturer's latest effort: an e-book that shows children making allergy-friendly swaps at a school event.

Valeant leverages Rx sales force, YouTube for OTC brand

Valeant leverages Rx sales force, YouTube for OTC brand

The company is supporting its professional pitch for the acne drug with a micro-targeted marketing strategy.

Pharma fixed in online traffic patterns, despite distrust: survey

A good percentage of consumers are open to visiting a pharmaceutical company website, an online survey shows, despite a persistent undercurrent of distrust for industry.

Novo taps five experts for their brash take on menopause

Novo taps five experts for their brash take on menopause

The drug maker brought together a group of five established healthcare advocates under the umbrella GLAM, short for Great Life After Menopause. The advocates will keep their distinct voices, which are anything but muted.

Blogs may smooth ups, downs of breast cancer: study

For women suffering from breast cancer, online tools appeared to be helpful in battling depression, a randomized trial showed.

Game for cancer patients gets mobile app

Game for cancer patients gets mobile app

Re-Mission, the video simulation known to change young patients' attitudes toward cancer, is in its second iteration. And one big drug maker has added its backing.

Remedy's HealthCentral.com is slated for a makeover

Remedy's HealthCentral.com is slated for a makeover

Remedy Health is hoping a new design for its flagship portal can give it an edge over rivals WebMD and Everyday Health.

Shire tackles diabetes from the bottom up

Shire tackles diabetes from the bottom up

How Shire's new campaign seeks to help diabetics start off on the right foot

NY'ers to get first taste of Big Data, as creation of state's patient portal gets under way

NY'ers to get first taste of Big Data, as creation of state's patient portal gets under way

The state's first patient portal has officially entered development, and the e-health firm leading the effort said that a former WebMD executive joined its board.

A Parkinson's app for patients that took its cue from HCPs

A Parkinson's app for patients that took its cue from HCPs

Patient use of the professional app prompted the latest iteration, and the foundation behind it is set to launch a media push.

Pharma digerati launch advisory firm

Pharma digerati launch advisory firm

The duo whose nonprofit served as neutral ground for getting FDA and industry talking about digital marketing is starting a for-profit research and advisory firm.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.